Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063

Amyloid deposition as the central event in the aetiology of Alzheimer’s disease

Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538

Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo

Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,802

Colorimetric determination of phospholipids with ammonium ferrothiocyanate

Stewart, J. C. M. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90269-9 · Cited by 1,786

Stability of curcumin in buffer solutions and characterization of its degradation products

Wang, Y., Pan, M., Cheng, A., Lin, L., Ho, Y., Hsieh, C., & Lin, J. (1997) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)02024-9 · Cited by 1,709

Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro

Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254

Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature

Anand, P., Thomas, S. G., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Sung, B., Tharakan, S. T., Misra, K., Priyadarsini, K. I., Rajasekharan, K. N., et al. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.008 · Cited by 1,205

Alzheimer's disease: strategies for disease modification

Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,075

The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug Delivery Platform

Hong, S., Leroueil, P. R., Majoros, I., Orr, B. G., Baker, J. R., & Holl, M. M. B. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.11.015 · Cited by 585

Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines

Rajpoot, K. (2020) · Current Drug Targets · doi:10.2174/1389450121666200106105633 · Cited by 12

Nanoparticles for Diagnosis and/or Treatment of Alzheimer's Disease

Antimisiaris, S. G., Mourtas, S., Markoutsa, E., Σκούρας, Α., & Παπαδιά, Κ. (2014) · Advanced Healthcare Materials · doi:10.1002/9781118774205.ch4 · Cited by 11

18 F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease

Rokka, J., Snellman, A., Kaasalainen, M. H., Salonen, J., Zona, C., Ferla, B. L., Nicotra, F., Re, F., Masserini, M., Forsback, S. J., et al. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.03.016 · Cited by 10

Pharmaceutical Applications of Curcumin-Loaded Nanoparticles

Rai, M., Pandit, R., Paralikar, P., Nagaonkar, D., Rehman, F., & dos Santos, C. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-70299-5_6 · Cited by 12

Soluble curcumin prevents cadmium cytotoxicity in primary rat astrocytes by improving a lack of GFAP and glucose-6-phosphate-dehydrogenase

Nedzvetsky, V. S., Sukharenko, E. V., Kyrychenko, S. V., & Baydaş, G. (2018) · Regulatory Mechanisms in Biosystems · doi:10.15421/021875 · Cited by 10

Phytocompounds and lipid-based drug delivery system for neurodegenerative diseases

Özay, C., & Karpuz, M. (2024) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/apjtb.apjtb_455_24 · Cited by 8

Hemocompatibility of Amyloid and/or Brain Targeted Liposomes

Michanetzis, G. P. A. K., Markoutsa, E., Mourtas, S., Missirlis, Y. F., & Antimisiaris, S. G. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0236 · Cited by 8

Liposomes: Production Methods and Application in Alzheimer’s Disease

Naziris, N., & Demetzos, C. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-78787-5_48 · Cited by 7

Potential of nanoliposomes for the therapy and/or diagnosis of Alzheimer’s disease: recent progress

Antimisiaris, S. G. (2014) · Clinical Lipidology · doi:10.2217/clp.14.33 · Cited by 7

Neuroprotective Propensity of Curcumin: Evidence in Animal Models, Mechanisms, and Its Potential Therapeutic Value

Pradeep, H., Yenisetti, S. C., Rajini, P. S., & Muralidhara, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00016-5 · Cited by 8

Emerging paradigms in bioorthogonal chemistry for future therapeutics

Önder, M., Yılmaz, F. Z., Demirsoy, Z., & Gülseren, G. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126236 · Cited by 6

Beneficial Role of Curcumin in Preventing the Aggregation of the Amyloid-β Peptide in Alzheimer’s Disease

Banerjee, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00019-0 · Cited by 7

Nanoformulated herbal bioactives for the treatment of neurodegenerative disorders

Sajadimajd, S., Moradi, S. Z., Akbari, V., Aghaz, F., & Farzaei, M. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824385-5.00008-x · Cited by 6

Targeting the Pathological Hallmarks of Alzheimer’s Disease Through Nanovesicleaided Drug Delivery Approach

Roy, R., Bhattacharya, P., & Borah, A. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220526094802 · Cited by 6

Lipid Nanocarriers as an Alternative for the Delivery of Bioactive Compounds Beneficial to Health

de Quadros, C. D. C., Araújo, A. C. D. S., Latorres, J. M., Michelon, M., & Salas‐Mellado, M. D. L. M. (2023) · Current Bioactive Compounds · doi:10.2174/1573407219666230306142421 · Cited by 6

Targeting Amyloids with Coated Nanoparticles: A Review on Potential Combinations of Nanoparticles and Bio-Compatible Coatings

Warerkar, O. D., Mudliar, N. H., Momin, M. M., & Singh, P. K. (2023) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2023046209 · Cited by 7

Brain targeting with lipidic nanocarriers

Antimisiaris, S. G., Mourtas, S., & Παπαδιά, Κ. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813667-6.00007-3 · Cited by 5

Applications of Nanomaterials in Neurological Diseases, Neuronal Differentiation, Neuronal Protection, and Neurotoxicity

Alhibshi, A., Alamoudi, W., & Farooq, R. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-4802-4_6 · Cited by 5

Drugs and Drug Delivery Systems Targeting Amyloid-\b{eta} in Alzheimers DiseasePreprint

Robinson, M. J., Lee, B. Y., & Leonenko, Z. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1704.08313 · Cited by 5

The potential of curcumin in tissue engineering and nanotechnology-based drug delivery systems: A bibliometric analysis

Zıkşahna, K., Adıyıl, R., Özkan, M., & Ihlamur, M. (2025) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2025.102575 · Cited by 4

Neuroprotective Role of Piperine-Encapsulated Casein Micelles in Mitigating Intracellular Dyshomeostasis in Alzheimer’s Disease Pathology

Mishra, J., Singh, C., & Bhatti, J. S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05297-3 · Cited by 4

Evaluation of the Anti-Amyloid and Anti-Inflammatory Properties of a Novel Vanadium(IV)–Curcumin Complex in Lipopolysaccharides-Stimulated Primary Rat Neuron-Microglia Mixed Cultures

Katsipis, G., Lavrentiadou, S. N., Geromichalos, G. D., Tsantarliotou, M. P., Halevas, E. G., Litsardakis, G., & Pantazaki, Α. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010282 · Cited by 4

Alzheimer’s disease: unraveling role of xanthone derivatives and nanocarriers

Suhaili, I. N. A., Yow, H.-Y., Mah, S. H., Huri, H. Z., & Tan, S. L. J. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04446-8 · Cited by 4

Nanomedicine in Alzheimer’s Therapy: Enhancing Drug Delivery Strategies

Singh, A., Mazumder, A., Das, S., Mishra, R., & Chaitanya, M. (2024) · Current Nanomedicine · doi:10.2174/0124681873312057240622175745 · Cited by 3

Polyphenols as Potential Therapeutic Drugs in Neurodegeneration

de Laureto, P. P., Palazzi, L., & Acquasaliente, L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89575 · Cited by 3

Protective role of curcumin in cadmium-induced physiological and reproductive toxicity in male BALB/c mice

Shaw, R., Hati, R., Sharma, S., Deep, S., & Chaube, R. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100803 · Cited by 3

Antioxidant Nutraceuticals as Novel Neuroprotective Agents

Katiyar, P., Ghosh, S., Saini, S., Ghosh, C., Agrawal, H., Sircar, D., & Roy, P. (2022) · Wiley eBooks · doi:10.1002/9781119746843.ch8 · Cited by 4

Neurodegenerative Disease: Nanotechnology to Rescue

Doke, R. R., Lamkhade, G., Manchare, B. R., & Vinchurkar, K. (2025) · Springer eBooks · doi:10.1007/978-3-032-03604-9_19 · Cited by 3

Biopharmaceutical Monotargeting versus ‘Universal Targeting’ of Late-Onset Alzheimer’s Disease Using Mixtures of Pleiotropic Natural Compounds

Friel, H. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190127 · Cited by 2

Nanomaterial-based drug delivery systems as tools for targeted therapy of neurodegenerative diseases

Shukla, R., Srivastava, V., Sethi, A., & Ruwali, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00003-4 · Cited by 2

Targeting Assembly and Disassembly of Protein Aggregates

Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801944-3.00006-0 · Cited by 2

Brain targeted drug delivery using liposomes and polymeric nanocarriers: Pharmaceutical and preclinical perspectives in Alzheimer's and Parkinson's disease

Vojdanitalab, K., Naderi, M., Kalkhajeh, S. G., Sabetghadam, A., & Pashaki, S. R. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108200 · Cited by 3

Colloidal drug delivery system for brain-targeting therapy

Kuo, Y., & Wang, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-62614-1.00019-3 · Cited by 1

Nano-based phytodrug delivery systems for the management of neurodegenerative disorders

Sudheesh, M. S., & Pawar, R. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85544-0.00001-0 · Cited by 1

Effectiveness of Novel Drug Delivery System using Curcumin in Alzheimer’s Disease

Aswar, U. M., Rathod, K., & Mathure, D. M. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249279534240214111155 · Cited by 1

Immunomodulatory effects of curcumin in infectious and non infectious diseases

Shegokar, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40016-9.00008-7 · Cited by 1

Curcumin loaded drug delivery systems in the treatment of Alzheimer’s disease

Obulesu, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822448-9.00008-x · Cited by 1

Liposomal Membrane Modification, Polymers for

Deshpande, M., & Torchilin, V. P. (2015) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120050564 · Cited by 1

Multi-functionalized nanoparticles for therapy and diagnosis of alzheimer's disease

Salvati (2013)

Physicochemical Properties for Potential Alzheimer’s Disease Drugs

Ates-Alagoz, Z., & Adejare, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00005-2

Secondary Prevention of Alzheimer’s Disease

Friel, H., & Frautschy, S. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812259-4.00004-7

Nano Based Approach for the Neurological Disorder Treatments-A Scenario (A-Review)

Oli, A. K., Jain, A., Shivshetty, N., Javaregowda, P. K., & Chandrakanth, R. K. (2023) · Oriental Journal Of Chemistry · doi:10.13005/ojc/390205

Alzheimer's disease – An overview of nano herbal formulations

Patil, V. S., Patil, S., Patil, S. R., Pawar, A. S., & Shete, A. S. (2025) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2025.100042

Natural Product Assembly in Nanoformulation: Importance in Neurodegenerative Diseases

Verma, K., Singh, R., Jain, S., & Sharma, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-5088-3_6

The Effect of Free and Nanoliposomal Curcumin on the Viability and Acid Production of Single‐Species ( Streptococcus mutans ) and Polymicrobial Biofilms

Habibi, P., Yazdi, F. T., Mortazavi, S. A., & Farajollahi, M. M. (2026) · Clinical and Experimental Dental Research · doi:10.1002/cre2.70290

Utilisation de nanoparticules pour délivrer des protéines dans les épithéliums respiratoires : caractérisation des mécanismes impliqués

Dombu, C. Y. (2012) · theses.fr (ABES) · doi:10.70675/6051c377z57b3z4be0za648zaad0dbe9f570

Nanosondes épigénétiques

Bahhaj, F. E. (2014) · theses.fr (ABES) · doi:10.70675/3f140dd9z5f61z450az82ebz6ce2a732ee06

Mitochondria‐Targeted Curcumin Delivery: Therapeutic Strategies for Mitochondrial Dysfunction‐Related Disorders

Mishara, M. G., Singh, M., Chauhan, A. S., Nath, L. R., Sabitha, M., & Sudheesh, M. S. (2026) · Advanced Therapeutics · doi:10.1002/adtp.202500578

New [18F]Tracers for Alzheimer's Disease Imaging. Labeling Synthesis And Biological Testing

Rokka, J. (2015) · UTUPub (University of Turku)

Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide

Mourtas, S., Canovi, M., Zona, C., Aurilia, D., Niarakis, A., Ferla, B. L., Salmona, M., Nicotra, F., Gobbi, M., & Antimisiaris, S. G. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.027 · Cited by 234

Curcumin-conjugated Nanoliposomes with High Affinity for Aβ Deposits: Possible Applications to Alzheimer Disease

Lazar, A. N., Mourtas, S., Youssef, I., Parizot, C., Dauphin, A., Delatour, B., Antimisiaris, S. G., & Duyckaerts, C. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.004 · Cited by 149

Multifunctional Nanoliposomes with Curcumin-Lipid Derivative and Brain Targeting Functionality with Potential Applications for Alzheimer Disease

Mourtas, S., Lazar, A. N., Markoutsa, E., Duyckaerts, C., & Antimisiaris, S. G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.050 · Cited by 263

Comparison of Various Types of Ligand Decorated Nanoliposomes for their Ability to Inhibit Amyloid Aggregation and to Reverse Amyloid Cytotoxicity

Markoutsa, E., Mourtas, S., Bereczki, E., Zona, C., Ferla, B. L., Nicotra, F., Flores, O., Pei, J.-J., & Antimisiaris, S. G. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150605115902 · Cited by 10

Functionalization with curcumin-derivative and TAT peptide enhances the interaction with human brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide

SANCINI, G. A., Gregori, M., Zona, C., Masserini, M., Cambianica, I., & Salvati, E. (2012) · BOA (University of Milano-Bicocca)